BeOne Medicines (ONC) Raw Materials (2024 - 2026)

BeOne Medicines (ONC) has 3 years of Raw Materials data on file, last reported at $274.2 million in Q1 2026.

• Quarterly Raw Materials changed N/A year-over-year to $274.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $274.2 million (changed N/A YoY) and the FY2025 annual result came in at $236.2 million, up 38.46% from the prior year.
• Raw Materials rose to $274.2 million in Q1 2026 per ONC's latest filing, from $236.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $274.2 million in Q1 2026 and bottomed at $170.6 million in Q4 2024.
• The 3-year median for Raw Materials is $236.2 million (2025), against an average of $227.0 million.
• Peak annual rise in Raw Materials reached 38.46% in 2025, while the deepest fall reached 38.46% in 2025.
• Tracing ONC's Raw Materials over 3 years: stood at $170.6 million in 2024, then jumped by 38.46% to $236.2 million in 2025, then climbed by 16.1% to $274.2 million in 2026.
• Per Business Quant, the three latest ONC Raw Materials figures stand at $274.2 million (Q1 2026), $236.2 million (Q4 2025), and $170.6 million (Q4 2024).

Peer Comparison